US Stock MarketDetailed Quotes
SILO Silo Pharma
- 1.850
- 0.0000.00%
Close May 3 16:00 ET
5.26MMarket Cap-1541P/E (TTM)
1.850High1.770Low14.14KVolume1.790Open1.850Pre Close25.46KTurnover0.56%Turnover RatioLossP/E (Static)2.84MShares3.05052wk High0.85P/B4.70MFloat Cap1.21652wk Low--Dividend TTM2.54MShs Float19.500Historical High--Div YieldTTM4.32%Amplitude1.216Historical Low1.800Avg Price1Lot Size
About Silo Pharma Company
Silo Pharma, Inc. is a developmental stage biopharmaceutical company, which engages in the merging of traditional therapeutics with psychedelic research. It seeks to acquire and develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs. The company was founded by Eric Weisblum on July 13, 2010 and is headquartered in Sarasota, FL.
Company Profile
SymbolSILO
Company NameSilo Pharma
Listing DateSep 27, 2022
Founded2010
CEOMr. Eric Weisblum
MarketNASDAQ
Employees3
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address677 North Washington Boulevard
CitySarasota
ProvinceFlorida
CountryUnited States of America
Zip Code34236
Phone1-718-400-9031
Websitehttp://www.silopharma.com
Company Executives
- Name
- Position
- Salary
- Eric Weisblum
- Chairman of the Board, Chief Executive Officer and President
- 332.25K
- Daniel E. Ryweck
- Chief Financial Officer and Principal Accounting Officer
- 15.00K
- Dr. Kevin Munoz
- Independent Director
- 40.11K
- Dr. Jeff Pavell, M.D.
- Independent Director
- --
- Wayne D. Linsley
- Independent Director
- 60.11K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg